kallikrein:kininogen:cell surface receptor:factor XII -> kallikrein:kininogen:cell surface receptor + factor XIIa (kallikrein catalyst)

Stable Identifier
R-HSA-9909046
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
kallikrein:KNG1:(C1QBP,C1QBP:KRT1, PLAUR:KRT1):FXII -> FXIIa + kallikrein:KNG1:(C1QBP, C1QBP:KRT1, PLAUR:KRT1)
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Binding of factor XII (FXII) to cell surface receptors facilitates the assembly of high molecular weight kininogen (HK), prekallikrein (PK), and FXII into higher order ternary complexes, in which FXIIa and plasma kallikrein (PKa) mutually activate each other in a Zn²⁺-dependent manner, creating a positive feedback loop on the cell surface (Joseph K et al., 1999, 2001, 2004; Mahdi F et al., 2002, 2003; Kaira BG et al., 2020; reviewed by Pathak M et al., 2018). This Reactome event describes plasma kallikrein-catalyzed cleavage of FXII within the cell surface receptor complexes, leading to the release of activated FXIIa. The cell surface receptors involved in this process include complement C1q binding protein, encoded by the C1QBP gene, also known as globular C1q receptor (gC1qR), cytokeratin 1 (CK1, encoded by the KRT1 gene), and the urokinase plasminogen activator receptor (uPAR, encoded by the PLAUR gene). Both gC1qR (C1QBP) and uPAR (PLAUR) interact with CK1, forming heterodimers gC1qR:CK1 and uPAR:CK1 complexes, respectively. Additionally, gC1qR (C1QBP) may function as a homotrimer (Ghebrehiwet B et al., 1994; Joseph K et al., 1999, 2001, 2004; Mahdi F et al., 2002, 2003; Kaira BG et al., 2020; reviewed by Pathak M et al., 2018). Although gC1qR, CK1 and uPAR are expressed on various cell types, including activated platelets (Peerschke EIB et al., 2003; Khan MM et al., 2006; reviewed by Schmaier AH, 2016), FXII induced activation of the plasma kallikrein kinin system is thought to occur predominantly on endothelial cell surfaces (Lin Y et al., 1997; Motta G et al., 1998; Joseph K et al., 2001; Mahdi F et al., 2002, 2003; Pixley RA et al., 2011; Kaira BG et al., 2020).
Literature References
PubMed ID Title Journal Year
11204562 Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1

Joseph, K, Shibayama, Y, Ghebrehiwet, B, Kaplan, AP

Thromb Haemost 2001
25039405 Single-chain factor XII exhibits activity when complexed to polyphosphate

Engel, R, Brain, CM, Paget, J, Lionikiene, AS, Mutch, NJ

J Thromb Haemost 2014
14691562 The physiologic basis of assembly and activation of the plasma kallikrein/kinin system

Schmaier, AH

Thromb Haemost 2004
874082 Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Meier, HL, Pierce, JV, Colman, RW, Kaplan, AP

J Clin Invest 1977
32559765 Factor XII and kininogen asymmetric assembly with gC1qR/C1QBP/P32 is governed by allostery

Kaira, BG, Slater, A, McCrae, KR, Dreveny, I, Sumya, U, Mutch, NJ, Searle, M, Emsley, J

Blood 2020
11986212 Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes

Mahdi, F, Shariat-Madar, Z, Figueroa, CD, Schmaier, AH

Blood 2002
Participants
Participates
Catalyst Activity

serine-type endopeptidase activity of kallikrein:KNG1:(C1QBP,C1QBP:KRT1, PLAUR:KRT1):FXII [plasma membrane]

Orthologous Events
Authored
Reviewed
Created
Cite Us!